Roche

image

 

Roche Molecular Diagnostics cobas® Genomics and Oncology Division faced strong competition from other qPCR assays and Next Generation Sequencing (NGS), an emerging technology. We helped cobas® move from product to brand, leveraging the trust in Roche by oncologists and pathologists as a common connection, and emphasizing our actionable insights over broad mutation screening, leading to increased confidence in their personalized patient therapies.

image

image

image

Previous

HarborOne Bank
TransMedics

Next

clear-night

Chicago

17 degrees

cloudy

Boston

48 degrees

rain

Atlanta

57 degrees